Delivery Order SPE2DB20D1004-SPE2DB24FF3P3
Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $17K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of pharmaceutical supplies and medical materials such as the "MENQUADFI VIAL 0.5ML" product. The contract has a potential value of $1,756.20 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,512.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $47,395.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and the award was made through DLA's Troop Support Medical program without any set-aside designation. This delivery order is part of a larger,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products and medical supplies. The delivery order, valued at $6,038.37, is for the provision of MENQUADFI VIAL 0.5ML and has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a part of a larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of MENQUADFI VIAL 0.5ML, with a potential value of $2,107.44 and a completion date of January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564017415 MENQUADFI VIAL 0.5ML. The contract has a ceiling value of $10,537.20 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to deliver...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award has a potential value of $35,124.00 and a completion date of January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has received numerous...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. The contract has a potential value of $1,756.20 and a completion date of March 5, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA that has a potential value of up to $999,999,999.00 and a performance...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,350,644 units of the MENQUADFI VIAL 0.5ML pharmaceutical product. The contract has a completion date of January 19, 2024 and a potential value of $4,214.88. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $74,097.05 award is for the supply of 4563225576 ! MENQUADFI VIAL 0.5ML, a pharmaceutical product. The delivery order has a completion date of January 4, 2024 and was awarded on January 3, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has received...